Clorox Q4 net sales flat, gross margin compressed; announces streamlined operating model; FY23 cautious

CLOROX CO /DE/

2022-FY EPS reported $3.73 revenue$7,107,000,000

Q4 net sales flat at $1.8B; organic sales +1%; diluted EPS $0.81 (+4% YoY); adjusted EPS $0.93 (-2%).
FY22 net sales $7.1B (-3% YoY); gross margin 35.8% vs 43.6% prior year; free cash flow $535M vs $945M.
Health & Wellness segment volume -18% in Q4; net sales -5% despite pricing benefits; three-year avg growth +3%.
Announces streamlined operating model to create faster, simpler company, move decision-making closer to consumers.
FY23 outlook: environment remains difficult with inflation and portfolio normalization; expects margin rebuilding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.